Encapsulated naringenin seemed to be more active than naringenin alone, therefore, in this context, the inhibition of TNF-α blocked their activity, and this could reduce the interaction among the immune system and keratinocytes in psoriasis. This evidence concerns the gene TNF and psoriasis.